Arrivent Biopharma, Inc. · NASDAQ:AVBP
HBM Healthcare Investments (Cayman) Ltd. reported a 5.40% stake in Arrivent Biopharma, Inc. (Schedule 13G)
Event Oct 8, 2025 · Filed Oct 15, 2025
HBM Healthcare Investments (Cayman) Ltd. reported a 5.40% stake in Arrivent Biopharma, Inc., 2,195,014 shares, as a passive investor on Oct 8, 2025. Filed Oct 15, 2025 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 2,195,014
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd. | 5.40% | 2,195,014 |
Source
Related
- Arrivent Biopharma, Inc.
- HBM Healthcare Investments (Cayman) Ltd.
- Arrivent Biopharma, Inc. shareholders
- Schedule 13G · Vivo Opportunity, LLC · Oct 13, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Oct 8, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · Sofinnova Venture Partners IX, L.P. ("SVP IX") · Mar 5, 2026